# HighLevel Hygiene Packet — 2026-05-08 Agent Targeting Placeholders

Task: `t_f24c95c9`
Prepared for: Jeff / Whiteford Schell IP
Prepared by: highlevel-ops
Prepared at: 2026-05-08T08:50:22Z / 2026-05-08T02:50:22-0600
HighLevel location: Whiteford Schell IP (`tm68WWMrcAa3TqQbEAMa`)
Pipeline: Whiteford Schell IP Pipeline (`Tbx4tA6wHv5lTwZPSHyZ`)
Current stage: Agent Targeting (`fd569cf4-979b-43b8-bd0f-78e807e80ff1`)
Mode: APPROVAL ONLY — no live HighLevel mutations, sends, tags, workflow enrollment, LinkedIn action, social post, Clio write, or stage movement were performed by this packet.

## Executive decision

Keep RADICL, Manifest OS, and Sereact as internal Agent Targeting placeholders only. The parent reviewer approved the existing live HighLevel records only as company-level DND CRM staging: contacts and opportunities exist, but no external action is approved.

Recommended immediate approval scope for Jeff: approve internal-only HighLevel hygiene notes and optional internal remediation tasks for the exact contact/opportunity IDs below. Do not add marketing tags, workflow-trigger tags, personal emails/phones, LinkedIn profile enrichment, workflow enrollment, newsletters, campaigns, social posts, Clio entries, or Targeting Packet Ready movement.

## Source artifacts used

- Parent reviewer report: `docs/nightly-lead-research/runs/2026-05-08/nightly_qwen_prospect_digest_review_t_7129d706.md`
- Validation report: `docs/nightly-lead-research/runs/2026-05-08/validation_report.md`
- Candidate packet: `docs/nightly-lead-research/runs/2026-05-08/prospect_candidates.json`
- Parent task metadata from `t_7129d706`, which lists the verified HighLevel contact/opportunity IDs below.
- Local Growth OS database reference from validation report: `/Users/jeff/.openclaw/projects/mountain-west-growth-os/data/growth-os.sqlite`

Note: the raw qwen digest's initial `no HighLevel writes` wording is stale because later parent tasks synced company-level DND placeholders and open Agent Targeting opportunities. This packet treats the parent reviewer report as the controlling approval/safety record.

## Sync and safety status to preserve

Parent review confirms:

- Company-level DND contacts are live in HighLevel.
- Opportunities are open in Agent Targeting only.
- Current HighLevel location is `tm68WWMrcAa3TqQbEAMa`.
- Current pipeline is `Tbx4tA6wHv5lTwZPSHyZ`.
- Current stage is Agent Targeting (`fd569cf4-979b-43b8-bd0f-78e807e80ff1`).
- No external outreach, social/LinkedIn action, workflow enrollment, Clio write, public action, or stage movement is approved.
- Local Growth OS state remains `pipeline_stage=agent-targeting`, `suppression_status=consent_gap_no_auto_send`, and `conflicts_status=required_before_send`.
- Local suppression/conflict checks are not cleared: `local_suppression_status=not_checked`, `local_clio_precheck_status=not_checked`, `whiteford_conflicts_status=required_before_send`, `opt_out_status=not_checked`, `duplicate_prior_touch_status=not_checked`, and `final_clearance=not_cleared`.
- Supabase is partial only; expanded evidence/outreach/CRM/content tables are still missing remotely and must not be used as the sole launch-review surface.

## Records requiring hygiene markings

| Company | Prospect ID | Lane | HighLevel contact ID | HighLevel opportunity ID | Current status | Primary hygiene issue |
| --- | --- | --- | --- | --- | --- | --- |
| RADICL (Radicl Defense LLC) | `prospect_2180fd85f6085ebc2a595f72` | Tech GC primary; AI Compliance and AI Patent secondary | `PngYMpg9XtRzFutqkzKH` | `7Ckk70HMCvAKBuMH5QBu` | Open in Agent Targeting | Strong Boulder/DIB cybersecurity fit, but no consent/conflicts/suppression/Clio/duplicate-prior-touch clearance. BizJournals funding/hiring detail is paywall-sensitive/secondary and should not be standalone external copy evidence. |
| Manifest OS | `prospect_647f303b12467f9d88c68da4` | Tech GC primary; national/legaltech targeting caveat | `bEuSTw2QeCCF43JihiW8` | `JYNAZFRcioNguDNdz7tm` | Open in Agent Targeting | High-value legaltech target but not Mountain West; national legaltech targeting requires Jeff decision. Dan Mishin is above threshold; David Schellhas is below named-recipient threshold. Avoid adversarial/irony framing externally without attorney tone review. |
| Sereact | `prospect_ef30df45ad62c93981758ca3` | AI Patent watchlist | `1a2gBW9IhpZfgnh6bT2K` | `hUevEZZwjvyALchVzSzv` | Open in Agent Targeting | Strong AI robotics patent watchlist fit, but Germany/no Mountain West anchor, international-targeting caveat, and named contact evidence is low-confidence/non-official. No named-recipient or social action until official verification. |

## Approval packet: exact internal-only notes

If Jeff approves live hygiene writes, add one internal note to the corresponding opportunity and/or company-level contact. These notes are intentionally internal, non-marketing, and do not authorize external action.

### RADICL (Radicl Defense LLC)

Target IDs:
- Contact: `PngYMpg9XtRzFutqkzKH`
- Opportunity: `7Ckk70HMCvAKBuMH5QBu`

Proposed internal note:

```text
INTERNAL AGENT TARGETING PLACEHOLDER — NO AUTO-SEND / NO WORKFLOW / NO STAGE MOVEMENT.

Nightly 2026-05-08 research record for RADICL (Radicl Defense LLC). Keep DND enabled. Do not send email/SMS, enroll in any workflow/campaign/newsletter, add marketing or workflow-trigger tags, perform LinkedIn/social action, add personal contact data, write to Clio, or move beyond Agent Targeting without Jeff's exact approval.

Reviewer status: approved only as internal attorney-review research lead. Tech GC / AI compliance fit is strong because Boulder HQ, DIB cybersecurity, AI-vSOC, CMMC/NIST, and growth signals align with Whiteford/Schell IP offer lanes. Use first-party RADICL homepage, leadership, and investor pages as primary copy evidence. Treat BizJournals funding/hiring details as paywall-sensitive/secondary and do not use them as standalone external copy evidence unless independently verified from accessible sources.

Known contacts from public-source research: Chris Petersen and Dave Graff appear above internal confidence threshold, but no consent, conflicts, Clio precheck, opt-out, duplicate-prior-touch, or final clearance is complete. No named-recipient outreach is authorized.

Required before any external action: source-current review, exact recipient/handle verification, suppression/opt-out/duplicate-prior-touch review, Whiteford conflicts clearance, final copy/channel/timing approval by Jeff, and explicit authorization for the exact action.
```

### Manifest OS

Target IDs:
- Contact: `bEuSTw2QeCCF43JihiW8`
- Opportunity: `JYNAZFRcioNguDNdz7tm`

Proposed internal note:

```text
INTERNAL AGENT TARGETING PLACEHOLDER — NO AUTO-SEND / NO WORKFLOW / NO STAGE MOVEMENT.

Nightly 2026-05-08 research record for Manifest OS. Keep DND enabled. Do not send email/SMS, enroll in any workflow/campaign/newsletter, add marketing or workflow-trigger tags, perform LinkedIn/social action, add personal contact data, write to Clio, or move beyond Agent Targeting without Jeff's exact approval.

Reviewer status: approved only as internal attorney-review / national-targeting-decision research lead. Tech GC/legaltech fit may be high, but Manifest OS is not a Colorado/Mountain West company. Jeff must approve a broader national legaltech targeting rationale before any external-path copy or prioritization. Use Manifest OS first-party Series A page plus BusinessWire/LegalTechTalk for funding/model facts. LinkedIn evidence must not be scraped or automated.

Contact posture: Dan Mishin appears above internal confidence threshold; David Schellhas is below the 75 named-recipient threshold and should not be used as a named outreach target. No consent, conflicts, Clio precheck, opt-out, duplicate-prior-touch, or final clearance is complete. Avoid the draft packet's `irony angle` externally unless Jeff/attorney tone review approves exact final copy; it could sound adversarial or imply legal-risk conclusions.

Required before any external action: Jeff approval for national/legaltech targeting, source-current review, exact recipient/handle verification, suppression/opt-out/duplicate-prior-touch review, Whiteford conflicts clearance, final copy/channel/timing approval by Jeff, and explicit authorization for the exact action.
```

### Sereact

Target IDs:
- Contact: `1a2gBW9IhpZfgnh6bT2K`
- Opportunity: `hUevEZZwjvyALchVzSzv`

Proposed internal note:

```text
INTERNAL AGENT TARGETING PLACEHOLDER — NO AUTO-SEND / NO WORKFLOW / NO STAGE MOVEMENT.

Nightly 2026-05-08 research record for Sereact. Keep DND enabled. Do not send email/SMS, enroll in any workflow/campaign/newsletter, add marketing or workflow-trigger tags, perform LinkedIn/social action, add personal contact data, write to Clio, or move beyond Agent Targeting without Jeff's exact approval.

Reviewer status: approved only as AI Patent watchlist / source-verification research. Company-level AI robotics fit is strong, but Sereact is Germany-based with no Mountain West anchor. International AI patent targeting requires Jeff's express approval before any external-path copy or prioritization. Official domain supports company-level AI robotics fit, but named leadership/funding evidence in the packet relies on low-confidence/non-official public source; do not use named contacts externally until official company/press/filing/credible database verification upgrades contact confidence.

Contact posture: Dr. Ralf Gulde and Marc Tuscher are both below the 75 named-recipient threshold in the staged packet; no LinkedIn/person URLs are verified; no consent, conflicts, Clio precheck, opt-out, duplicate-prior-touch, or final clearance is complete. Treat as watchlist/research-only.

Required before any external action: official source/contact verification, Jeff approval for international AI patent targeting, source-current review, exact recipient/handle verification, suppression/opt-out/duplicate-prior-touch review, Whiteford conflicts clearance, final copy/channel/timing approval by Jeff, and explicit authorization for the exact action.
```

## Approval packet: exact internal HighLevel tasks

If Jeff approves live hygiene writes, create one internal task per opportunity. Suggested owner: Jeff or an approved HighLevel/Growth OS operator. Suggested due date: next business day or before the next prospecting review session, whichever is earlier. These are internal research-remediation tasks only.

### RADICL task

```text
Task title: Remediate internal Agent Targeting placeholder — RADICL
Related contact ID: PngYMpg9XtRzFutqkzKH
Related opportunity ID: 7Ckk70HMCvAKBuMH5QBu
Task body: Remediate RADICL source and approval blockers before any outreach/social/workflow/Clio action. Use first-party RADICL homepage, leadership, and investor pages as primary copy evidence. Do not use BizJournals funding/hiring details as standalone external evidence unless independently verified from accessible sources. Verify any named recipient or social handle manually. Re-run suppression, opt-out, duplicate-prior-touch, local Clio precheck, and Whiteford conflicts checks. Keep DND, no sends, no workflow enrollment, no marketing tags, no LinkedIn/social action, no Clio write, no stage movement, and no personal contact enrichment until Jeff approves exact recipient/channel/copy/timing.
```

### Manifest OS task

```text
Task title: Resolve targeting posture and remediate internal Agent Targeting placeholder — Manifest OS
Related contact ID: bEuSTw2QeCCF43JihiW8
Related opportunity ID: JYNAZFRcioNguDNdz7tm
Task body: Resolve whether Manifest OS belongs in a broader national legaltech targeting lane before any outreach/social/workflow/Clio action. Use Manifest OS first-party Series A page plus BusinessWire/LegalTechTalk for funding/model facts. Do not use David Schellhas as a named-recipient target unless later verification clears the below-threshold contact confidence issue. Do not use irony/adversarial framing externally without attorney tone review and exact-copy approval. Verify any named recipient or social handle manually. Re-run suppression, opt-out, duplicate-prior-touch, local Clio precheck, and Whiteford conflicts checks. Keep DND, no sends, no workflow enrollment, no marketing tags, no LinkedIn/social action, no Clio write, no stage movement, and no personal contact enrichment until Jeff approves exact recipient/channel/copy/timing.
```

### Sereact task

```text
Task title: Verify source/contact posture for AI Patent watchlist — Sereact
Related contact ID: 1a2gBW9IhpZfgnh6bT2K
Related opportunity ID: hUevEZZwjvyALchVzSzv
Task body: Treat Sereact as watchlist/source-verification only before any outreach/social/workflow/Clio action. Verify official company/press/filing/credible database evidence for leadership, funding, and named contacts; current named contacts are below the 75 confidence threshold and no person LinkedIn URLs are verified. Obtain Jeff's express approval for international AI patent targeting before preparing external-path copy. Re-run suppression, opt-out, duplicate-prior-touch, local Clio precheck, and Whiteford conflicts checks. Keep DND, no sends, no workflow enrollment, no marketing tags, no LinkedIn/social action, no Clio write, no stage movement, and no personal contact enrichment until Jeff approves exact recipient/channel/copy/timing.
```

## DND / no-auto-send safeguards

For any later approved hygiene write, the operator must preserve these safeguards:

1. DND remains enabled on all three company-level contacts.
2. No email address, mobile number, personal LinkedIn URL, or named-recipient enrichment is added unless Jeff separately approves exact fields and source evidence.
3. No tags are added, especially no `workflow:*`, campaign, newsletter, nurture, or segmentation tags.
4. No workflow/campaign/newsletter/enrollment action is taken.
5. No opportunity is moved out of Agent Targeting.
6. No opportunity owner, stage, status, value, close date, or source field is changed unless separately approved.
7. No HighLevel task body may instruct a human to contact the company; tasks must remain internal remediation only.
8. No LinkedIn/company-page/social draft is scheduled, posted, tagged, commented, or messaged.
9. No Clio write occurs; local Clio precheck remains `not_checked` until a separately approved conflicts workflow is run.
10. If any future write is approved, read back contacts/opportunities after writing and verify no tags/workflows/sends/stage movement occurred.

## Optional safe cleanup scopes Jeff may approve later

These options are ordered from safest to highest-risk. None is authorized by this packet.

1. Preferred: add internal notes only.
   - Preserves audit trail while making blockers visible.
   - Conditions: DND stays on; tags stay empty; no workflows; no sends; no stage moves; no personal contact enrichment; no Clio write.

2. Add internal notes plus internal remediation tasks.
   - Useful if Jeff wants a queue for source/conflicts/suppression cleanup.
   - Conditions: tasks must be internal-only and must not instruct a human to contact the prospect.

3. Add an opportunity-name prefix, e.g. `[INTERNAL HOLD] RADICL — Agent Targeting`.
   - Pros: visible from pipeline board/list views.
   - Cons: mutates live opportunity names and can clutter reporting.
   - Approval needed: exact final opportunity names and IDs.

4. Add a non-automation custom field such as `Growth OS Research Status = Internal Hold — Source/Conflicts Pending`.
   - Pros: reportable hygiene marker without tags.
   - Cons: custom-field creation and workflow dependencies must be checked first.
   - Approval needed: field name, values, and confirmation no automations trigger from it.

5. Delete/archive placeholders only if Jeff decides risk exceeds audit value.
   - Pros: reduces accidental-use risk.
   - Cons: loses live CRM audit continuity and may invite duplicate recreation.
   - Approval needed: export/readback first, exact contact/opportunity IDs, and separate delete/archive confirmation.

## Explicitly forbidden now

- Do not send email, SMS, DMs, newsletters, campaigns, or sequence messages.
- Do not enroll any workflow, campaign, newsletter, or nurture sequence.
- Do not add marketing tags, workflow-trigger tags, segmentation tags, or suppression tags.
- Do not add LinkedIn URLs, personal emails, phone numbers, or named-recipient outreach details.
- Do not publish, schedule, comment, tag, or otherwise act on LinkedIn/company-page/social content.
- Do not scrape LinkedIn or automate individual profile activity.
- Do not move any opportunity beyond Agent Targeting.
- Do not create, update, or sync Clio records.
- Do not treat local suppression, opt-out, duplicate-prior-touch, Clio precheck, final clearance, or Whiteford conflicts as cleared.
- Do not rely on Supabase/dashboard alone for launch decisions until expanded schema installation and full mirror verification are complete.
- Do not use Manifest OS `irony angle` externally without attorney tone review and Jeff exact-copy approval.
- Do not use Sereact named contacts externally until official/high-confidence verification clears the contact-confidence threshold.

## Jeff approval checklist

Before any live HighLevel write, Jeff should choose one exact scope:

- `APPROVE INTERNAL NOTES ONLY for RADICL/Manifest OS/Sereact IDs listed in t_f24c95c9 packet.`
- `APPROVE INTERNAL NOTES AND TASKS for RADICL/Manifest OS/Sereact IDs listed in t_f24c95c9 packet.`
- `APPROVE OPPORTUNITY NAME PREFIX ONLY with exact final names.`
- `APPROVE NON-AUTOMATION CUSTOM FIELD PLAN ONLY after dependency check.`
- `DO NOT MUTATE HIGHLEVEL; remediate locally first.`
- `DELETE/ARCHIVE PLACEHOLDERS` only after export/readback and separate exact-delete confirmation.

Recommended approval: internal notes plus internal remediation tasks only, with no tags, no sends, no workflows, no stage movement, no LinkedIn/social action, no Clio write, and no personal contact enrichment.

Separate strategic decisions before any external-path work:

- Manifest OS: approve or reject broader national legaltech targeting rationale.
- Sereact: approve or reject international AI patent watchlist / targeting rationale.
- RADICL: confirm source-current copy basis using first-party/non-paywalled evidence before any external copy.

## Operator QA checklist for any later approved hygiene write

Before writing:
- Confirm location ID is `tm68WWMrcAa3TqQbEAMa`.
- Confirm pipeline ID is `Tbx4tA6wHv5lTwZPSHyZ`.
- Confirm stage is Agent Targeting (`fd569cf4-979b-43b8-bd0f-78e807e80ff1`).
- Confirm all target IDs match this packet.
- Confirm DND remains enabled.
- Confirm no tag/workflow/social/campaign/stage/Clio/write scope is bundled into the note/task approval.
- Confirm Manifest OS and Sereact targeting caveats have not been silently waived.

After writing, if approved later:
- Read back each note/task.
- Verify DND remains enabled.
- Verify no tags were added.
- Verify no workflows were enrolled.
- Verify no stage movement occurred.
- Verify no email/SMS/social/LinkedIn/Clio action occurred.
- Save verification artifact and add it to `docs/KANBAN_DELIVERABLE_INDEX.md`.

## Final gate

Status: HOLD IN AGENT TARGETING.

No prospect-facing external action is approved until source-current review, recipient/handle verification, suppression/opt-out/duplicate-prior-touch checks, local Clio precheck, Whiteford conflicts clearance, exact final copy/channel/timing, and Jeff approval are complete.
